Targeted Inhibition of p21 Promotes the Growth of Breast Cancer Cells and Impairs the Tumor-Killing Effect of the Vaccinia Virus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeted Inhibition of p21 Promotes the Growth of Breast Cancer Cells and Impairs the Tumor-Killing Effect of the Vaccinia Virus

Published:2024 Issue: Volume:27 Page:
ISSN:1738-6756
Container-title:Journal of Breast Cancer
language:en
Short-container-title:J Breast Cancer

Author:

Jia Xiaoyuan¹^ORCID,Zhao Yujia¹,Li Qiang¹^ORCID,Lu Xiaming²,Wang Xiaoyan³,Wang Hui³,Shi Ziyi¹,Xu Yipeng¹,Huang Biao¹^ORCID,Huang Fang²,Wang Yigang¹^ORCID

Affiliation:

1. College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.

2. Cancer Center, Department of Pathology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, China.

3. Oncology Department, Zhejiang Xiaoshan HospitaI, Hangzhou, China.

Funder

Natural Science Foundation of Zhejiang Province

Zhejiang Sci-Tech University

Basic Public Welfare Research Program of Zhejiang Province

Zhejiang Medical Technology Plan Project

Hangzhou Science and Technology Bureau

Hangzhou Medical Health Science and Technology Project

Publisher

XMLink

Link

https://ejbc.kr/pdf/10.4048/jbc.2024.0063

Reference39 articles.

1. Breast cancer

2. Triple negative breast cancer cell lines: One tool in the search for better treatment of triple negative breast cancer

3. Insights into the Behavior of Triple-Negative MDA-MB-231 Breast Carcinoma Cells Following the Treatment with 17β-Ethinylestradiol and Levonorgestrel

4. Estrogen Actions in Triple-Negative Breast Cancer

5. Triple-negative breast cancer molecular subtyping and treatment progress

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP